Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Avacta Group Share News (AVCT)
AVCT Share
Price
AVCT Share
News2
AVCT Share
Chat222
AVCT Share
Trades365
AVCT
Live RNS1
AVCT Share
Charts
AVCT Level 2
Console
AVCT Live
Share Price
AVCT Broker
Ratings
AVCT Directors
Deals
AVCT Financial
Diary
AVCT
Fundamentals
AVCT Short
Positions
AVCT
Media
AVCT Company
Research
AVCT Company
Timeline3
Share Price Information for Avacta Group (AVCT)
Last checked at -
Last checked at 
Intraday Avacta Group Share Chart
Avacta Group News
Avacta joint venture completes fresh funding round
(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group announced on Thursday that AffyXell, its joint venture with Daewoong Pharmace...
Avacta joint venture completes funding for lead cell therapy programme
(Alliance News) - Avacta Group PLC on Thursday said that its joint venture AffyXell with Daewoong Pharmaceuticals Co Ltd has successfully completed a ...
Avacta's partner LG Chem renews licence to develop Affimer platform
(Alliance News) - Avacta Group PLC said on Thursday that LG Chem Life Sciences has exercised its renewal option as part of an ongoing collaboration wi...
AIM WINNERS & LOSERS: Deltic rises on Shell deal; Windar down on delay
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Avacta shares up as cancer drug AVA6000 advances to third dose cohort
(Alliance News) - Avacta Group PLC said on Wednesday its candidate for multiple forms of cancer, AVA6000 Pro-doxorubicin, is advancing to its third do...
IN BRIEF: Avacta joint venture expands partnership with GenScript
Avacta Group PLC - Cambridge, England-based drug developer and diagnostics company - Says its joint venture AffyXell with Seoul, South Korea-based dru...
Avacta increases shareholding in drug developer AffyXell to 22%
(Alliance News) - Avacta Group PLC said on Wednesday it increased its shareholding in its South Korean joint venture, AffyXell Therapeutics.
Follow the stocks
